OMDA Omada Health, Inc.

Nasdaq www.omadahealth.com


$ 24.90 $ -0.05 (-0.18 %)    

Wednesday, 05-Nov-2025 09:59:20 EST
QQQ $ 621.87 $ 3.46 (0.56 %)
DIA $ 472.20 $ 1.33 (0.28 %)
SPY $ 677.20 $ 2.19 (0.32 %)
TLT $ 89.42 $ -0.09 (-0.1 %)
GLD $ 365.56 $ -0.89 (-0.24 %)
$ 25.36
$ 25.29
$ 24.80 x 9
$ 25.30 x 300
$ 25.20 - $ 25.30
$ 14.14 - $ 28.40
675,377
na
557.18M
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWee...

Core News & Articles

Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $24 to ...

Core News & Articles

Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that sho...

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Omada Health (NASDAQ:OMDA) with a Neutral rating and announces Price...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $27...

Core News & Articles

Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $21 to ...

Core News & Articles

Needham analyst Ryan MacDonald maintains Omada Health (NASDAQ:OMDA) with a Buy and raises the price target from $23 to $24.

Core News & Articles

Financial OutlookFor the year ending December 31, 2025, Omada expects:Revenue in the range of $235 million to $241 millionAdjus...

Core News & Articles

Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.14...

Core News & Articles

Evercore ISI Group maintains Omada Health (NASDAQ:OMDA) with a Outperform and raises the price target from $21 to $23.

 omada-health-analysts-say-buy--while-its-still-below-ipo-price

Omada Health is poised to generate over 35% growth while approaching adjusted EBITDA breakeven, Needham analysts say.

Core News & Articles

JP Morgan analyst Destiny Jackson initiates coverage on Omada Health (NASDAQ:OMDA) with a Overweight rating and announces Pr...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach initiates coverage on Omada Health (NASDAQ:OMDA) with a Overweight rating and announ...

Core News & Articles

Goldman Sachs analyst David Roman initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Price Tar...

Core News & Articles

Barclays analyst Saket Kalia initiates coverage on Omada Health (NASDAQ:OMDA) with a Overweight rating and announces Price T...

Core News & Articles

Needham analyst Ryan MacDonald initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Price Target...

Core News & Articles

Canaccord Genuity analyst Richard Close initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Pri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION